Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis
References (114)
- et al.
Graphic representation of pain
Pain
(1976) - et al.
Relation between initial blood pressure and its fall with treatment
Lancet
(1985) - et al.
A method for assessing the quality of a randomized control trial
Controlled Clin Trials
(1981) - et al.
Reporting standards and research strategies for controlled trials. Agenda for the Editor
Controlled Clin Trials
(1980) - et al.
Content of reports on clinical trials: a critical review
Controlled Clin Trials
(1984) - et al.
Phenylbutazone in rheumatoid arthritis
J Chron Dis
(1957) Controversies and achievements in clinical trials
Controlled Clin Trials
(1984)- et al.
Uses and abuses of analysis of covariance in clinical trials
Controlled Clin Trials
(1985) Primary, secondary, and meta-analysis of research
Educ Res
(1976)- et al.
Meta-analyses of randomized controlled trials
N Engl J Med
(1987)
Reference bias in reports of drug trials
Br Med J
(1987)
Elementary Medical Statistics
(1963)
Regression towards mediocrity in hereditary stature
J Anthropol Inst Great Britain Ireland
(1885–1886)
Biometry
(1981)
Non-parametric Statistical Methods
(1973)
Clinical trials. A practical approach
(1983)
Anonymous: Diagnostic criteria for rheumatoid arthritis. 1958 revision
Ann Rheum Dis
(1959)
Therapeutic criteria in rheumatoid arthritis
JAMA
(1949)
Rational choice of dose: insufficient background knowledge?
Ration Drug Ther
(1986)
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
Q J Med
(1968)
Experimental Designs
(1957)
The two-period change-over design and its use in clinical trials
The use of non-parametric methods in the statistical analysis of the two-period change-over design
Biometrics
(1972)
The two-period cross-over clinical trial
Br J Clin Pharmacol
(1979)
Statistical Methods in Medical Research
(1971)
An additional basic science for clinical medicine: II. The limitations of randomized trials
Ann Intern Med
(1983)
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design
Br J Cancer
(1976)
Some thoughts on clinical trials, especially problems of multiplicity
Science
(1977)
Comparing the means of several groups
N Engl J Med
(1985)
Measurement in Medicine: The Interpretation of Numerical Data
(1968)
The clinical measurement of pain
Ann New York Acad Sci
(1960)
The estimation of inflammatory activity in rheumatoid arthritis. Role of composite indices
Arthr Rheum
(1967)
The epidemiology of the gastrointestinal randomized clinical trial
N Engl J Med
(1977)
Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities
Eur J Clin Pharmacol
(1981)
Clinical research in general medical journals
N Engl J Med
(1979)
Deficiencies of randomized control trials
Clin Res
(1978)
Reporting on methods in clinical trials
N Engl J Med
(1982)
Reporting clinical trials in general surgical journals
Surgery
(1984)
Is the clinical trial evidence about new drugs statistically adequate?
Br J Clin Pharmacol
(1985)
Use of check lists in assessing the statistical content of medical studies
Br Med J
(1986)
Variations in response to non-steroidal, anti-inflammatory drugs
Br J Clin Pharmacol
(1982)
Problems in publication of clinical trial methodology
Clin Pharmacol Ther
(1979)
Enalapril, atenolol, and hydrochlorothiazide in hypertension (letter)
Lancet
(1986)
Ascorbic acid for the common cold. A prophylactic and therapeutic trial
JAMA
(1975)
How blind is double blind? And does it matter?
Br J Clin Pharmacol
(1976)
The evaluation of antirheumatic drugs
Curr Med Res Opin
(1973)
Clinical Trials
(1980)
A seven-day variability study of 499 patients with peripheral rheumatoid arthritis
Arthr Rheum
(1965)
Clinical judgement analysis—practical application in rheumatoid arthritis
Br J Rheumatol
(1983)
Cited by (288)
Bias Assessment in Outcomes Research: The Role of Relative Versus Absolute Approaches
2021, Value in HealthCitation Excerpt :For the quality effects model, bias adjustment was achieved using additional data in the model (relative ranks) apart from the usual effect size and standard error.22,23 We examined the same 25 quality assessment scales18,24-47 to keep consistency with those reported previously3,17 and used their most recent version if available47 (Appendix Table 2 in Supplemental Materials found at https://doi.org/10.1016/j.jval.2021.02.011). All distinct bias safeguard items from the 25 scales were examined and trimmed of items deemed to be reporting quality only (see Appendix Table 3 in Supplemental Materials found at https://doi.org/10.1016/j.jval.2021.02.011 for final list).
Stratification by quality-induced selection bias in a meta-analysis of clinical trials
2019, Journal of Clinical EpidemiologyManagement of Rheumatoid Arthritis and the Pharmacist's Role
2019, Encyclopedia of Pharmacy Practice and Clinical Pharmacy: Volumes 1-3Management of rheumatoid arthritis and the pharmacist’s role
2019, Encyclopedia of Pharmacy Practice and Clinical Pharmacy
Copyright © 1989 Published by Elsevier Inc.